|
 |
Tradename |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
|
Abiplatin |
Republic of South Africa |
|
Accocit |
Mexico |
|
Briplatin |
Japan |
|
Cisplatex |
Brazil |
|
Cisplatin |
Australia, Austria, Belgium, Canada, Saudi Arabia |
|
Cisplatina |
Brazil |
|
Cisplatine |
Belgium, France |
|
Cisplatyl |
France, Greece, Saudi Arabia, Turkey |
|
Citoplatino |
Argentina, Italy |
|
Citoplax |
Brazil |
|
Corsis |
Mexico |
|
Insel |
Brazil |
|
Neoplatin |
Spain |
|
Pamifect |
India |
|
Placis |
Spain, Turkey |
|
Platamine |
Greece, Italy, Morocco, Tunisia |
|
Platanovag |
Argentina |
|
Platiblastin |
Austria |
|
Platidiam |
Hungary, Poland |
|
Platinex |
Germany, Great Britain, Italy |
|
Platinol |
Austria, Belgium, Denmark, Finland, Greece, Luxembourg, Mexico, Netherlands, Sweden, Switzerland, United States of America |
|
Platistil |
Spain |
|
Platistine |
Belgium, Brazil, Luxembourg |
|
Platosin |
Belgium, Egypt, Greece, Japan, Netherlands, Romania, Turkey, Venezuela |
|
Pronto Platamine |
Italy |
|
Zuridry |
Mexico |
|
|
 |
 |
Compatibility : Cisplatin |
|
|
|
|
|
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
|
|
